<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04636164</url>
  </required_header>
  <id_info>
    <org_study_id>2020-3233</org_study_id>
    <nct_id>NCT04636164</nct_id>
  </id_info>
  <brief_title>Deep Neural Networks on the Accuracy of Skin Disease Diagnosis in Non-Dermatologists</brief_title>
  <official_title>Effect of Using Deep Neural Networks on the Accuracy of Skin Disease Diagnosis in Non-Dermatologist Physician</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pyoeng Gyun Choe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Deep neural networks (DNN) has been applied to many kinds of skin diseases in&#xD;
      experimental settings.&#xD;
&#xD;
      Objective: The objective of this study is to confirm the augmentation of deep neural networks&#xD;
      for the diagnosis of skin diseases in non-dermatologist physicians in a real-world setting.&#xD;
&#xD;
      Methods: A total of 40 non-dermatologist physicians in a single tertiary care hospital will&#xD;
      be enrolled. They will be randomized to a DNN group and control group. By comparing two&#xD;
      groups, we will estimate the effect of using deep neural networks on the diagnosis of skin&#xD;
      disease in terms of accuracy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the DNN group and control group, these steps are the same process.&#xD;
&#xD;
        1. Routine exam and capture photographs of skin lesions for all eligible consecutive series&#xD;
           patient.&#xD;
&#xD;
        2. Make a clinical diagnosis (BEFORE-DX)&#xD;
&#xD;
        3. Make a clinical diagnosis (AFTER-DX)&#xD;
&#xD;
        4. consult to dermatologist&#xD;
&#xD;
      In the DNN group, after making the BEFORE-DX, physicians use deep neural networks and make an&#xD;
      AFTER-DX considering the results of the deep neural networks (Model Dermatology, build 2020).&#xD;
&#xD;
      In the control group, after making the BEFORE-DX, physicians make an AFTER-DX after reviewing&#xD;
      the pictures of skin lesions once more.&#xD;
&#xD;
      Ground truth will be based on the biopsy if available, or the consensus diagnosis of the&#xD;
      dermatologists.&#xD;
&#xD;
      We will compare the accuracy between the DNN group and control group after 6 consecutive&#xD;
      months study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Top-1 diagnostic accuracy</measure>
    <time_frame>6 consecutive months</time_frame>
    <description>frequency of correct Top-1 prediction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Top-2 and 3 diagnostic accuracy</measure>
    <time_frame>6 consecutive months</time_frame>
    <description>frequency of correct Top-2 and 3 prediction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection sensitivity</measure>
    <time_frame>6 consecutive months</time_frame>
    <description>positive rate of infection diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malignancy sensitivity</measure>
    <time_frame>6 consecutive months</time_frame>
    <description>Positive rate of malignancy diagnosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Skin Diseases</condition>
  <arm_group>
    <arm_group_label>DNN group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>using deep neural networks for skin lesion diagnosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional diagnosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Model Dermatology (deep neural networks; Build 2020)</intervention_name>
    <description>Physicians in the DNN group take pictures of the skin lesion and use the algorithm by uploading pictures.</description>
    <arm_group_label>DNN group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  non-dermatologist physician (residents) who agree to participate in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  dermatology residents&#xD;
&#xD;
          -  non-dermatology residents who use other deep neural networks for skin lesion diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pyoeng Gyun Choe, MD</last_name>
    <phone>82-02-2072-4187</phone>
    <email>pgchoe@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chan Mi Lee, MD</last_name>
    <phone>82-10-3147-5519</phone>
    <email>heaven229@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan Mi Lee, MD</last_name>
      <phone>82-10-3147-5519</phone>
      <email>heaven229@naver.com</email>
    </contact>
    <investigator>
      <last_name>Pyoeng Gyun Choe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Wang P, Liu X, Berzin TM, Glissen Brown JR, Liu P, Zhou C, Lei L, Li L, Guo Z, Lei S, Xiong F, Wang H, Song Y, Pan Y, Zhou G. Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study. Lancet Gastroenterol Hepatol. 2020 Apr;5(4):343-351. doi: 10.1016/S2468-1253(19)30411-X. Epub 2020 Jan 22. Erratum in: Lancet Gastroenterol Hepatol. 2020 Apr;5(4):e3.</citation>
    <PMID>31981517</PMID>
  </reference>
  <reference>
    <citation>Lin H, Li R, Liu Z, Chen J, Yang Y, Chen H, Lin Z, Lai W, Long E, Wu X, Lin D, Zhu Y, Chen C, Wu D, Yu T, Cao Q, Li X, Li J, Li W, Wang J, Yang M, Hu H, Zhang L, Yu Y, Chen X, Hu J, Zhu K, Jiang S, Huang Y, Tan G, Huang J, Lin X, Zhang X, Luo L, Liu Y, Liu X, Cheng B, Zheng D, Wu M, Chen W, Liu Y. Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial. EClinicalMedicine. 2019 Mar 17;9:52-59. doi: 10.1016/j.eclinm.2019.03.001. eCollection 2019 Mar.</citation>
    <PMID>31143882</PMID>
  </reference>
  <reference>
    <citation>Liu Y, Jain A, Eng C, Way DH, Lee K, Bui P, Kanada K, de Oliveira Marinho G, Gallegos J, Gabriele S, Gupta V, Singh N, Natarajan V, Hofmann-Wellenhof R, Corrado GS, Peng LH, Webster DR, Ai D, Huang SJ, Liu Y, Dunn RC, Coz D. A deep learning system for differential diagnosis of skin diseases. Nat Med. 2020 Jun;26(6):900-908. doi: 10.1038/s41591-020-0842-3. Epub 2020 May 18.</citation>
    <PMID>32424212</PMID>
  </reference>
  <reference>
    <citation>Han SS, Park I, Eun Chang S, Lim W, Kim MS, Park GH, Chae JB, Huh CH, Na JI. Augmented Intelligence Dermatology: Deep Neural Networks Empower Medical Professionals in Diagnosing Skin Cancer and Predicting Treatment Options for 134 Skin Disorders. J Invest Dermatol. 2020 Sep;140(9):1753-1761. doi: 10.1016/j.jid.2020.01.019. Epub 2020 Mar 31.</citation>
    <PMID>32243882</PMID>
  </reference>
  <reference>
    <citation>Sellheyer K, Bergfeld WF. A retrospective biopsy study of the clinical diagnostic accuracy of common skin diseases by different specialties compared with dermatology. J Am Acad Dermatol. 2005 May;52(5):823-30.</citation>
    <PMID>15858472</PMID>
  </reference>
  <reference>
    <citation>Cui X, Wei R, Gong L, Qi R, Zhao Z, Chen H, Song K, Abdulrahman AAA, Wang Y, Chen JZS, Chen S, Zhao Y, Gao X. Assessing the effectiveness of artificial intelligence methods for melanoma: A retrospective review. J Am Acad Dermatol. 2019 Nov;81(5):1176-1180. doi: 10.1016/j.jaad.2019.06.042. Epub 2019 Jun 27. Review.</citation>
    <PMID>31255749</PMID>
  </reference>
  <reference>
    <citation>Tschandl P, Codella N, Akay BN, Argenziano G, Braun RP, Cabo H, Gutman D, Halpern A, Helba B, Hofmann-Wellenhof R, Lallas A, Lapins J, Longo C, Malvehy J, Marchetti MA, Marghoob A, Menzies S, Oakley A, Paoli J, Puig S, Rinner C, Rosendahl C, Scope A, Sinz C, Soyer HP, Thomas L, Zalaudek I, Kittler H. Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study. Lancet Oncol. 2019 Jul;20(7):938-947. doi: 10.1016/S1470-2045(19)30333-X. Epub 2019 Jun 12.</citation>
    <PMID>31201137</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 13, 2020</study_first_submitted>
  <study_first_submitted_qc>November 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2020</study_first_posted>
  <last_update_submitted>November 13, 2020</last_update_submitted>
  <last_update_submitted_qc>November 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Pyoeng Gyun Choe</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>skin diseases, deep neural networks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

